Lipodystrophy, Familial Partial, Type 2 (FPLD2)

Alias:

Fpld2

Familial Partial Lipodystrophy, Dunnigan Type

Familial Partial Lipodystrophy Type 2

Lipoatrophic Diabetes

Lipoatrophic Diabetes Mellitus

Familial Partial Lipodystrophy Dunnigan Type

Dunnigan Syndrome

Fpl2

Generalized Lipoatrophy Associated with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy and Leukomelanodermic Papules

Lipodystrophy, Familial, of Limbs and Lower Trunk

Familial Lipodystrophy of Limbs and Lower Trunk

Lipodystrophy Familial of Limbs and Lower Trunk

Lipodystrophy, Familial Partial, Dunnigan Type

Familial Partial Lipodystrophy, Type 2

Lipodystrophy, Familial Partial, 2

Familial Generalized Lipodystrophy

Diabetes Mellitus, Lipoatrophic

Lipodystrophy, Reverse Partial

Reverse Partial Lipodystrophy

Lipodystrophy Reverse Partial

Favorite

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Lipodystrophy, Familial Partial, Type 2, also known as fpld2, is related to lipodystrophy, congenital generalized, type 1 and lipodystrophy, familial partial, type 1, and has symptoms including myalgia An important gene associated with Lipodystrophy, Familial Partial, Type 2 is LMNA (Lamin A/C), and among its related pathways/superpathways are Metabolism and Nervous system development. The drugs Empagliflozin and Hypoglycemic Agents have been mentioned in the context of this disorder. Affiliated tissues include skin and liver, and related phenotypes are diabetes mellitus and hepatomegaly

Related ID：

MALACARDS：LPD015

OMIM：151660

MESH：D003923